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a b s t r a c t
Background:Depression is common in chronic heart failure (CHF) and associatedwith adverse outcomes.
Knowing the risk factors for thedevelopment of depression at the early post-hospitalizationphasemaybe
a key factor of successful disease management programs. The aim of this study was therefore to identify
the risk factors related to the onset of depression after heart failure hospitalization in patients with CHF.
Methods: The study population included participants with an admission diagnosis of acute heart fail-
ure or exacerbation of CHF from a multicenter prospective cohort study. Patients completed clinical
evaluation at discharge and functional and social status assessment at 1 month after discharge, and
depressive symptoms using the Hospital Anxiety and Depression Scale (HADS-D) at discharge and
1-year later.
Results:Of the 131 patientswithout depression at discharge, 29 (22.1%) had developed signiﬁcant depres-
sive symptoms (HADS-D≥8) at 1-year follow-up.Multiple logistic regressiondemonstrated thatprevious
ischemic heart disease [odds ratio (OR) 3.09, 95% conﬁdence interval (CI) 1.15–8.33], participation restric-
tions (OR 0.43, 95% CI 0.26–0.70), and lack of satisfaction with social support (OR 0.48, 95% CI 0.29–0.79)
were independent predictors of developing depression.
Conclusions: The three clinically accessible variables and targets for interventions identiﬁed as predictors
in this study may help to guide the optimal post-discharge disease management planning for these
risk fo
3 Jappatients who are at high
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Depression is a commoncondition in chronicheart failure (CHF),
ncreasing the risk of adverse outcomes and poor health status,
nd is an important public health concern [1,2]. Clinically signif-
cant depression is estimated to occur in 21.5% of CHF patients
nd increase sharply with increase in CHF severity [1]. Depressed
HF patients experience a more rapid loss of physical function [3],
oorer health-related quality of life, more frequent readmissions,
nd higher mortality rates than non-depressed CHF patients inde-
endently of CHF disease severity [1].
Despite the deleterious consequences of depression in CHFatients, fewstudies focusedon theonset of post-dischargedepres-
ion. The depression may constitute a transient dysphoric mood
nd often worsen with discharge from the hospital [4]. Moreover,
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increasing or new-onset depressive symptoms have been associ-
ated with worse outcomes in CHF patients [5]. Such data suggest
that preventing worsening depressive symptoms in CHF patients
can improve their health. Some researchers have looked at the
change in depression symptom severity in CHF patients [6,7]; how-
ever, this has not been examined in post-discharge depression.
Previous studies suggest that a post-discharge support program
involving targeted psychiatric management can be effective and
improve health outcomes for patients with CHF [8,9].
Furthermore, few studies have examined the relationship
between functional status and the onset of depression. Functional
status represents their ability to do basic activities and participate
in life situations [10]. To optimize outcomes inpost-dischargeman-
agement programs, an understanding of the relationship between
baseline functional status and subsequent depressive symptoms
is essential. This may be particularly important in advanced heart
failure patients who have been deﬁned as having persistent severe
symptoms and functional limitations despite routine therapy [11].
The aim of this study was therefore to identify the risk fac-
tors including functional status related to the onset of depressive
symptoms after heart failure hospitalization in patients with CHF.
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ethods
tudy design and patients
The present study is a predeﬁned sub-study of a large, multi-
enter cohort study in Japan: the Preventive Effect of Exercise for
anagement of Daily Functioning in Patients with CHF (PTMaTCH)
tudy—a rehabilitation cohort study of CHF patients [12]. PTMaTCH
rospectively investigates the prognostic inﬂuence of functional
imitations for CHF patients after discharge. We described the
TMaTCH study design previously in detail [13]. Brieﬂy, consent-
ng, eligible patients were assessed at the time of discharge and
ollowed up serially at 1, 3, 5, 12, and 24 months after discharge.
he studywas approved by the Ethics Review Boards of the Nagoya
niversity School of Medicine (approval no. 493) and the review
oards of all other participating hospitals. Written informed con-
ent was obtained from each of the patients before study entry.
he study coordination center in Nagoya, Japan, performed data
anagement.
InPTMaTCH,menandwomen,40yearsof ageorolder,whowere
dmitted to one of the 24 participating hospitalswith an admission
iagnosis of acuteheart failureor exacerbationofCHFbetweenMay
008 and May 2011, were eligible. Eligibility criteria included left
entricular ejection fraction (LVEF)≤40%, or plasma B-type natri-
retic peptide (BNP) level≥80pg/mL as well as New York Heart
ssociation (NYHA) functional classiﬁcation II–IV. Exclusion crite-
ia included the patients who (1) were unable to walk a minimal
istance (50m) with or without a walking aid; (2) had Mini-
ental State Examination (MMSE) scores≤18; (3) underwent
ardiac surgery during hospitalization; (4) had chronic obstructive
ulmonary disease; or (5) had severemental illness including diag-
osis of major depression. In addition to the PTMaTCH eligibility
riteria, patients were eligible for this analysis if they did not have
igniﬁcant depressive symptoms at discharge, deﬁned as aHospital
nxiety and Depression Scale for depression (HADS-D) score of ≥8.
redictor variables
As part of PTMaTCH, demographics, physical function variables,
heMMSE, and the HADS-Dwere assessed at the time of discharge.
he following clinical information was documented by the attend-
ng cardiologist: cause of heart failure and comorbidities, LVEF,
YHA functional classiﬁcation, discharge laboratory values, and
ischargemedications. The detailedmethods formeasurement are
ublished elsewhere [13]. Based on existing literature [6,14], eco-
omic and social potential risk factors for developing depression in
eart failure were also assessed. Economic burden of medical care
epresented how severely patients are affected on a 4-point Lik-
rt scale from ‘severe’ to ‘none’. The Social Support Questionnaire
SSQ-6) was used to measure social support. The SSQ-6 provides a
ist of 6 situationspotentially requiring social support andasked the
espondentwho they could rely on for help (social support amount)
nd their perceived satisfaction with help (satisfaction with social
upport) in each situation. The reliability and validity of the SSQ-6
ere reported previously [15].
To investigate the effect of functional status on onset of depres-
ion, two self-administered questionnaires were also assessed.
unctional status was measured using the Performance Measure
or Activities of Daily Living-8 (PMADL-8) [16] and the Participation
cale for Patients with CHF (PS-CHF) [17], developed speciﬁcally to
ssess functional limitations and participation in CHF patients and
overed functional status domain by deﬁnition [10]. The PMADL-
consists of 8-items in daily physical activity in CHF patients and
ssesses the extent towhichpatients currently feel difﬁculty inper-
orming daily physical activity using a 4-category response scale
rom 1 (very easy) to 4 (very hard). It is scored from 8 to 32, withdiology 64 (2014) 37–42
higher scores indicating more severe functional limitations. This
measure is both valid and reliable [16,18] and has been shown to
be associated with depression [13] and prognosis in CHF patients
[12]. The PS-CHF is composed of 5-items that assess the extent to
which patients are limited in interpersonal interactions and activ-
ities in community life [17]. The response options for each item
were presented using 4-point scales and summary score ranged
from 5 (lowest level of participation) to 20 points (highest level
of participation). Lower scores correspond with more participa-
tion restrictions. The PS-CHF has also good reliability and validity.
Because functional status reﬂectsdaily life, it couldnotbeevaluated
at the time of discharge. Data on functional status were therefore
collected 1 month after discharge.
Outcome variables
We used the 14-item HADS questionnaire [19] to screen for
depressive symptoms; it includes 7 items for depression. It has
good validity and speciﬁcity [20], is easy to administer, and has
been widely used in heart failure patients [21] and psychiatric
patients [20]. Responses are made on a 4-point scale, and pos-
sible scores range from 0 to 21, with higher scores indicating
higher levels of depressive symptoms. Consistent with previous
research [20], participants in the PTMaTCH studywere categorized
as having depression (HADS-D≥8). The HADS-D was completed
initially at the time of discharge (baseline) and then repeated at 3,
5, 12, and 24months after discharge by postal questionnaire in the
PTMaTCH study. To examine the onset of depressive symptoms,
12 months HADS-D were analyzed as outcome variables in this
study.
Statistical analysis
Subjects who developed depression over the one year of
follow-up were compared with those who did not develop depres-
sion using chi-squared analysis and independent group t-tests.
Chi-squared tests were used for categorical variables and the inde-
pendent group t-test was used for continuous variables.
Univariate analyseswereused to examine the relationsbetween
each of the candidate predictor variables and the outcome vari-
ables (depression at one year as indicated by an HADS-D score ≥8).
Variables with a signiﬁcance level below 0.15 in univariate analy-
sis were selected for the multivariate logistic regression analyses.
The signiﬁcant variables were tested for multicollinearity. If the
correlation coefﬁcient was >0.90, the variable with the lowest cor-
relation coefﬁcient in relation to the outcomemeasurewas omitted
from the analysis. Then multiple logistic regression was utilized to
deﬁne the independent association between the candidate predic-
tor variables and one-year depression status. In the multivariable
model, we used a combined stepwise (backward and forward) pro-
cedure to obtain the ﬁnal signiﬁcant multivariate predictors that
had a univariate p value <0.15 and retaining those variables with
p<0.05 in the ﬁnal model. The SSQ-6, PMADL-8, and PS-CHF were
categorized by quartiles because linearity on the logit scale could
not be achievedwith this continuous covariate. Performance of the
ﬁnal models was evaluated using the c-statistic. Adequate calibra-
tionof theﬁnalmodelwas conﬁrmedusing theHosmer–Lemeshow
test. In secondary analyses, we examined the association between
the incidence of depression and the number of independent risk
factors. Because clinically meaningful cut off points in SSQ-6 and
PS-CHF are not well deﬁned, lower satisfaction score of the SSQ-6
and lower PS-CHF score were deﬁned by less than median score
(satisfaction with social support of SSQ-6 score <31 and PS-CHF
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Statistical analyses were conducted using SPSS for Windows
version 19.0; SPSS Inc., Chicago, IL, USA). All statistical tests were
wo-tailed, and p<0.05 deﬁned statistical signiﬁcance.
esults
Of the 254 patients assessed for eligibility in PTMaTCH, 76
29.9%) were excluded because they had already signiﬁcant
epressive symptoms at discharge (baseline). Of the 178 patients
atisfying the study criteria, 47 did not have one-year follow-up
ADS-D data: 4 patients had died, 21 were re-hospitalized with
cute exacerbation, 6 were hospitalized for reasons other than
eart failure, 6 withdrew from the study, 5 had incomplete data,
nd 5 were lost to follow-up. The remaining 131 patients formed
he analytic cohort for this study. Eligible patients with incomplete
ne-year follow-up data were likely to be older (p<0.05) and have
ower grip strength (p<0.05). No signiﬁcant differences in gender,
HF etiology, hypertension, diabetes, NYHA functional class, body
ass index, LVEF, BNP level, living alone,MMSEscore, self-reported
easure (e.g. SSQ-6), 6-min walking distance (6MWD), or HADS-
score at baseline were found between those with and without
omplete one-year follow-up data.
able 1
omparison of baseline characteristics between patients who developed depressive symp
New onset depression
Age (years) 67.1±13.0
Men (%) 23 (79.3)
Living alone (%) 6 (20.7)
MMSE (score) 26.8±3.2
Ischemic heart disease (%) 19 (65.5)
Comorbid conditions
Hypertension (%) 15 (51.7)
Diabetes (%) 14 (48.3)
Peripheral vascular (%) 0 (0.0)
Chronic kidney disease (%) 3 (10.3)
Stroke (%) 2 (6.9)
Medication
ACE inhibitor/ARB (%) 24 (82.8)
-Blockers (%) 21 (72.4)
Diuretics (%) 24 (82.8)
Digoxin (%) 4 (13.8)
Antidepressant medication (%) 1 (3.4)
LVEF≤30% (%) 11 (39.3)
BNP (pg/mL) 469±373
Serum hemoglobin (g/dl) 12.7±2.2
Serum sodium (mmol/L) 139.4±3.1
NYHA functional class on admission
II (%) 12 (41.4)
III (%) 8 (27.6)
IV (%) 9 (31.0)
6MWD (m) 337±105
Grip strength (kg) 25.8±11.2
Knee extensor muscle strength (Nm/kg) 1.0±0.6
Economic burden of medical care (%)
Severe 2 (6.9)
Moderate 11 (37.9)




Functional limitationsa (score) 21±6
Participationb (score) 9±3
alues aremean± SD or n (%). MMSE,Mini-Mental State Examination; ACE, angiotensin-co
raction; BNP, brain natriuretic peptide; NYHA, New York Heart Association; 6MWD, 6-m
mount.
a Functional limitations were measured using the Performance Measure for Activities o
b Participation was measured using the Participation Scale for Patients with chronic hediology 64 (2014) 37–42 39
Table 1 summarizes baseline characteristics of those with and
thosewithout depressive symptomsat 1-year follow-up.Of the131
patients without depressive symptoms at baseline, 29 (22.1%) had
developed signiﬁcant depressive symptoms at 1-year follow-up.
Factors signiﬁcantly related to the onset of depression were pre-
vious ischemic heart disease, low satisfaction with social support,
severe functional limitations, and low level of participation. The
markers of CHF disease severity at baseline showed no signiﬁcant
differences between the groups: LVEF; BNP level; NYHA func-
tional class; exercise capacityby the6MWD.Furthermore, variables
of previous ﬁndings were not signiﬁcantly different between the
groups; gender; living alone; economic burden of medical care;
hemoglobin level. Finally, there were no signiﬁcant differences
in baseline use of cardiovascular and antidepressant medications
between the two groups.
In themultivariable analyses, 10 variableswere originally tested
as candidate predictors of the onset of depression; of these, three
were found to contribute signiﬁcantly to the ﬁnal model, as shown
in Table 2. Previous ischemic heart disease, satisfaction with social
support, and participation restrictions as measured by the PS-
CHF were signiﬁcantly associated with the onset of depression.
However, functional limitations as measured by the PMADL-8
toms and did not.
Not depressed Statistic p
(n=29) (n=102)
68.5±9.8 t=0.5 0.59
63 (61.8) 2 = 3.1 0.08
14 (13.7) 2 = 0.8 0.36
27.7±2.8 t=1.4 0.17
43 (42.2) 2 = 4.9 0.03
70 (68.6) 2 = 2.8 0.09
33 (32.4) 2 = 2.5 0.12
1 (1.0) 2 = 0.3 0.59
5 (4.9) 2 = 1.2 0.28
4 (3.9) 2 = 0.4 0.51
82 (80.4) 2 = 0.1 0.78
82 (80.4) 2 = 0.9 0.35
87 (85.3) 2 = 0.1 0.74
23 (22.5) 2 = 1.1 0.30
1 (1.0) 2 = 0.9 0.40




















nverting enzyme; ARB, angiotensin receptor blocker; LVEF, left ventricular ejection
in walk distance; SSSAT, satisfaction with social support; SSAMT, social support
f Daily Living-8.
art failure.
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Table 2
Summary statistics for multivariable logistic regression model of predictors of depressive symptoms at one year.
Variable Beta Wald Chi-squared p OR 95% CI
Ischemic heart diseasea 1.13 4.96 0.03 3.09 1.15–8.33
SSSAT (quartile)† −0.74 8.15 <0.01 0.48 0.29–0.79
Participation (quartile)†† −0.86 11.02 <0.01 0.43 0.26–0.70
Intercept 1.80
OR, odds ratio; CI, conﬁdence interval; SSSAT, satisfaction with social support.
a Previous diagnosis of ischemic heart disease.
† Quartile range of SSSAT as measured by the Social Support Questionnaire were <30 score for the ﬁrst quartile, 30 score for the second quartile, 31–33 score for the third
quartile, and ≥34 score for the forth quartile.
































(uartile, 11–12 score for the third quartile, and ≥13 score for the forth quartile.
xtensor muscle strength, social support amount of Social Support Questionnaire s
id not reach statistical signiﬁcance. The resulting model had a
-statistic of 0.815, indicating moderately good discriminative
bility. The Hosmer–Lemeshow statistic for the model was 5.02
p=0.76), indicating good ﬁt for the model across the range of pre-
icted probabilities.
Fig. 1 summarizes the incidence of signiﬁcant depressive
ymptoms among patients with three risk factors. Participation
estrictionsasmeasuredby thePS-CHF, satisfactionwith social sup-
ort, and ischemic heart disease had graded relationships with the
ncidence of depression one year later (p<0.05 for each risk fac-
or). The risk of the onset of depression increased with the number
f risk factors (history of ischemic heart disease, lower satisfac-
ion score of the SSQ-6, and lower PS-CHF score); the incidence of
epression at one year was 0.0% of those with no risk factors, 16.8%
f those with one or two risk factors, and 70.6% of those with three
isk factors.
iscussion
Our study demonstrates that the onset of depression is a com-
on occurrence in heart failure patients after discharge and the
hree risk factors of the onset of depression were identiﬁed: pre-
ious ischemic heart disease, participation restrictions, and lack of
atisfaction with social support. Depressive symptoms developed
ig. 1. Incidence of depression at each risk factor. Ischemic, ischemic heart disease;
SSAT, satisfactionwith social support; Participation, Participation Scale for Patients
ith chronic heart failure. aPrevious diagnosis of ischemic heart disease. †Quartile
ange of SSSAT as measured by the Social Support Questionnaire were <30 score
or the ﬁrst quartile (Q1), 30 score for the second quartile (Q2), 31–33 score for the
hird quartile (Q3), and ≥34 score for the forth quartile (Q4). ††Quartile range of
articipation as measured by the Participation Scale for Patients with chronic heart
ailure were <8 score for the ﬁrst quartile (Q1), 8–10 score for the second quartile
Q2), 11–12 score for the third quartile (Q3), and ≥13 score for the forth quartile
Q4).odel was adjusted for gender, hypertension, diabetes, 6-min walk distance, knee
nd Performance Measure for Activities of Daily Living-8 score.
in 22% of CHF patients without depression at discharge and the
patient encountering three risk factors has a 70% increased risk for
the development of depressive symptoms over one year after dis-
charge.Most patientswith three risk factors had a chance of having
signiﬁcant depressive symptoms at one year. In contrast to many
heart failure depression studies, our prospective study examined
early post-discharge period characterized by changing clinical and
social settings [22]. Depressed patients have demonstrated lower
adherence to treatment, practicing self-monitoring, and following
lifestyle recommendations [23]. The early post-discharge period is
the time at which the patient is the most vulnerable and psycho-
logical distress may increase the risk of readmission, particularly
in depressed CHF patients [24]. Knowing the risk factors for the
development of depression in the early post-hospitalization phase
may allow physicians or allied health professionals to arrange the
optimal individualized post-discharge disease management.
We were able to identify two functional and social factors as
predictors for post-hospitalization heart failure depression; par-
ticipation restrictions and lack of satisfaction with social support.
The conceptualization of social isolation has been correlated with
depression in theelderlypopulation [25], but only a limitedamount
of information that is speciﬁc to heart failure is available [14]. A
previous study found that living alone was associated with the
developmentofdepressive symptomsover1-year follow-up inout-
patients with heart failure [6]. However, we found a relationship
with development of depression and participation restrictions and
lack of satisfaction with social support, but not with living alone.
Being alonemaynot necessarily lead to the development of depres-
sive symptoms, for example living alone can be experienced as
positive if chosen by the individual. Our ﬁndings may support the
notion that depression deﬁned as a subjective emotional state is to
be distinguished from the objective state of social isolation and is
thought to developwhen quality of relationships do notmeet one’s
need for attachment [26].
An additional focus of this report was to examine the relation-
ship between new-onset of depressive symptoms and functional
status composed of functional limitations and participation restric-
tion [10]. As stated above, our study found that participation
restrictions measured by the PS-CHF emerged as a signiﬁcant risk
factor for the development of depression. Although functional lim-
itations measured by the PMADL-8 were associated with the onset
of depression, functional limitations did not achieve statistical sig-
niﬁcance after adjustment. It is possible that disease severity in
our study population may affect these statistical results because
we excluded the patients with refractory end-stage heart failure.
Future studies are needed to examine these relationships including
patients with advanced heart failure.The results of this study provide several clinical implications.
First, routineandrepeatedscreening fordepressionmaybewarran-
ted forpost-dischargepatientswithCHF.Our study showthat22.1%
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ver 1-year post-discharge. In previous studies, we are aware of
nly twostudies investigatingdepression incidence.Havraneket al.
eported 21.9% patients developed depression during a one year
ollow-up in outpatients with heart failure using a Medical Out-
omes Study-Depression questionnaire [6]. In another study by
ossnitzer et al., incidence of depression one year later was 12.9%
n a sample of heart failure patients recruited from CNHF sub-
roject by the Patient Health Questionnaire 9-item depression
odule [27]. Although their study and our study have method-
logical differences, the incidence of post-discharge depression in
ur study is sufﬁciently high. To our knowledge, this is the ﬁrst
tudy to examine the incidence rate of depression after discharge.
levated depression symptoms are associated with mortality and
ardiac hospitalization, and nonadherence to both pharmacologic
nd behavioral recommendations [5]. By recognizing and treating
epression in heart failure patients, clinicians may improve adher-
nce to preferred heart failure treatment after discharge. Another
mplication involves the recognition and treatment of depression.
n this study, patients with participation restrictions and lack of
ubjective social support had high risk for developing depression.
hese two risk factors are potentially modiﬁable and are targets
or interventions such as multidisciplinary monitoring and psy-
hosocial support. Previous studies suggest that post-discharge
upport programs involving targeted psychiatric management can
e effective to treat depression and improve health outcomes for
atients with CHF [8,9]. A recent report also suggests a need for a
isease management program addressing both psychological and
eart failure aspects to improvehealth outcomes for depressedCHF
atients [28]. Future studies are needed to examine the effect of the
isease management programs involving screening and psychoso-
ial support inhigh-riskCHFpatients forpreventingdepressionand
mproving patient outcomes.
The causal mechanisms for the elevated incidence of depres-
ion in patients with CHF are unclear, but our data regarding risk
actors for the onset of depression provide some suggestions. In
meta-analysis of ﬁve cross-sectional studies, disease severity, as
easured by NYHA class, is a strong correlate of depression [1].
owever, we have demonstrated that NYHA functional class did
ot emerge as a signiﬁcant risk factor for depression, and this is
onsistent with previous work [6]. Furthermore, LVEF and BNP lev-
lswere not correlatedwith the onset of depression. These ﬁndings
uggest that depression might exacerbate the symptoms of heart
ailure and increase the severity of functional impairment, but, in
ontrast, heart failure severity (measuredbyNYHA functional class,
VEF, and BNP levels) may not deﬁne the direction of depression.
ther pathophysiologic pathways such as neurohormonal activa-
ion, rhythm disturbances, inﬂammation, and hypercoagulability
ight provide a convincing explanation for the increase in depres-
ion in heart failure patients [14]. A recent study has reported that
ome laboratory variables (including hemoglobin and leukocytes),
hich are related to levels of inﬂammatory markers, were cor-
elated with depression [29]. In our study, however, hemoglobin
evels did not show an association with developing depression,
nd this is consistent with previous work [27]. Further research
ncluding more speciﬁc inﬂammatory biomarkers is warranted to
xamine systemic inﬂammation and its sequelae impact on the risk
f depression.
Several limitations should be considered in the interpreta-
ion of the present ﬁndings. First, this is an observational study.
nobserved confounding factors could account for the observed
elation between the onset of depression and risk factors. Our study
onsidered CHF severity,medical comorbidity, demographic differ-
nces, and physical functional variables. An experimental design
ssessing the effects of depression prevention programs targeting
igh-risk groups would provide strong evidence for cause-effect
elationships of these risk factors and adverse outcomes. Second,
[diology 64 (2014) 37–42 41
the HADS-D measures depressive symptoms and is not a formal
diagnostic tool for major depressive disorder. However, the diag-
nostic accuracy of the HADS-D for major depression is relatively
high and is comparable to other depression screening instruments
[20,21]. In addition, multiple studies in heart failure popula-
tions have demonstrated the prognostic importance of depressive
symptoms measured by screening tools, irrespective of a formal
diagnosis ofmajor depression [1]. Finally, our samplewas relatively
small, limiting the number of variables we could reasonably exam-
ine bymultivariable analysis. However, this is unlikely to invalidate
the signiﬁcant predictors that we found.
In conclusion, our study can identify three risk factors for the
onset of depression in the post-discharge period: ischemic heart
disease, participation restrictions, and lack of satisfaction with
social support. These risk factors should be taken into account in
planning post-discharge disease management programs as well as
screening and intervention programs for the patients who are at
high risk for nonadherence to recommended treatment and read-
mission. Future studies are needed to examine the effect of the
post-discharge disease management programs involving targeted
psychosocial interventions in CHF patients for preventing depres-
sion and improving patient outcomes.
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